AzTrials
AzTrials

General AnesthesiaPLANNNCT06909227

Relevance of Veinous Lactates to Predict Postoperative Complications in Children 0-1 Years

An observational study of General Anesthesia and Infant, run by Hôpital Armand Trousseau at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study will investigate if the dosage of veinous lactate at the end of a surgical procedure is related to post-operative complications occurring within 3 months in young infants aged 0-1 years. Read more about this study

Who is it for?
Ages 0 years to 1 year
Conditions the study is for
General Anesthesia, Infant
What is being tested?
surgery under general anesthesia
Type of treatment
Surgery or procedure
How many people
500 participants
Where
1 siteFrance
Study dates
27 Mar 2025to 30 Sep 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 0 years to 1 year
  • All sexes
  • No healthy volunteers
  • Child

Study population: Children requiring a surgical procedure

Who may be able to join

  • surgery under general anesthesia
  • age < 1 year

Who cannot join

  • ambulatory surgery
  • cardiac surgery
  • preoperative hemodynamic instability
  • Weight < 2 kg

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Mireille Nasr, MD contact

+33667601819

mireille.nasr@aphp.fr

Nada Sabourdin, MD, PhD contact

+33667185789

nada.sabourdin@aphp.fr

France1 site, 1 recruiting
  • Armand Trousseau University Hospital

    Paris, 75012

    Mireille Nasr, MD, +33667601819, mireille.nasr@aphp.fr

    Mireille Nasr, MD

    Recruiting

Other trials in France

About this study

Official title: Relevance of Veinous Lactates Dosage at the End of a Surgical Procedure to Predict Postoperative Complications in Children 0-1 Years

This study will investigate if the dosage of veinous lactate at the end of a surgical procedure is related to post-operative complications occurring within 3 months in young infants aged 0-1 years.

Blood samples are acquired routinely before emergence of general anesthesia, from the IV line put in place for anesthesia.

The investigators hypothesized that elevated lactates would be associated with more postoperative complications in this population, as is the case in adults.

Being tested
surgery under general anesthesia
Keywords
pediatric, anesthesia, lactate, complications

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • surgery under general anesthesiaProcedure or surgery

    Only in children, < 1 year old non-cardiac surgery

Study groups in NCT06909227
Study groupRoleWhat they receive
infants 0-1 years undergoing surgery under general anesthesiaNot including day-case surgery, or cardiac surgery
Receives: Procedure: surgery under general anesthesia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Post-operative complications occurring within 3 months after surgery

    ICU admission Re-operation Re-admission Death

    Measured: within 3 months after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Apr 2025
  2. Study start27 Mar 2025
  3. Primary completion30 Sep 2026 (estimated)
  4. Study completion30 Sep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06909227
Sponsor's protocol ID
PLANN
Acronym
PLANN
Status last verified
Apr 2025
First submitted
27 Mar 2025
Last updated
1 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Will have to check adherence to confidentiality protocols.

Publications

  • Zheng D, Yu GL, Zhou YP, Zhang QM, Wang CG, Zhang S. Association between lactic acidosis and multiple organ dysfunction syndrome after cardiopulmonary bypass. PeerJ. 2024 Jan 31;12:e16769. doi: 10.7717/peerj.16769. eCollection 2024.

    PubMed 38313014
  • Stephens EH, Epting CL, Backer CL, Wald EL. Hyperlactatemia: An Update on Postoperative Lactate. World J Pediatr Congenit Heart Surg. 2020 May;11(3):316-324. doi: 10.1177/2150135120903977.

    PubMed 32294015

Questions about this trial

What is this clinical trial studying?

An observational study of General Anesthesia and Infant, run by Hôpital Armand Trousseau at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 1 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mireille Nasr, MD (+33667601819, mireille.nasr@aphp.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Post-operative complications occurring within 3 months after surgery (time frame: within 3 months after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06909227, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in